American Manufacturers’ Share of U.S. Market Hits New Low
A new index measures the amount of manufactured goods consumed in the U.S. that are made here opposed to imported.
Will China Products be Banned from U.S. Military Bases?
The House Armed Services Committee passed its version of the National Defense Authorization Act this week, with many amendments taking swipes at China reliance.
Katherine Tai Defends Section 301 China Tariffs in Senate Hearing
In one of her best hearings yet, USTR Katherine Tai holds fast on why the U.S. needs the Section 301 tariffs on China.
China Solar Stocks Rise by 10%-Plus After Not Making Forced Labor List
Homeland Security’s report to Congress on June 17 calls out Xinjiang Daqo New Energy, but leaves out its Shanghai operation listed on the NYSE.
What We Learned from the Latest China Hearing in Washington
The latest Congressional-Executive Commission on China heard from a State and Homeland official on China’s surveillance abroad. What can be done?
FDA Advancements Act Passes Committee, Sets Stage for Fall Reauthorization Passage
The FDA Safety and Landmark Advancements (FDASLA) Act has passed a key committee, with 25 out of some 30 amendments passing. Generics and baby formula crisis got most of the attention.
Harry Moser: Is the U.S. Succeeding at Reshoring?
Harry Moser of the Reshoring Initiative gives his assessment of America’s reshoring efforts in testimony to the U.S. China Economic and Security Review Commission.
Defense Official Makes Case Against Biden’s Anti-American Solar Policy
Deborah Rosenblum of the Department of Defense tells the U.S. China Economic and Security Review Commission that Washington has to reshore critical supply chains.
Does China Have Any Comparative Advantages? If So, How to Counter Them.
The U.S. China Economic and Security Review Commission asked panelists to discuss just how powerful, and important, China supply chains have become to the U.S. economy.
New Thinking Needed on Supply Chain Resilience
The U.S. China Economic and Security Review Commission heard from panelists this week on Washington’s reshoring efforts. Question: Will there be any buyers?
